Home Tags Drug Development

Drug Development Related Content

reduce drug costs, carbon emissions

‘Green’ asthma inhalers would reduce drug costs

Researchers at Cambridge have found that 'green' asthma inhalers would both reduce carbon emissions and reduce drug costs.
Medical devices policy

Medical devices policy: Japan’s Ministry of Health, Labour and Welfare

Here, we look at medical devices policy of Japan’s Ministry of Health, Labour and Welfare. The Ministry now has Katsunobu Katō in place, who very recently replaced Nemoto Takumi as the Minister of Health, Labour and Welfare in the country.
your chemistry

Getting your chemistry right

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the importance of getting your chemistry right.
regulation of hepatitis B

Multi-step regulation of hepatitis B virus entry

Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.
non communicable diseases in africa, endocrine disruptors

Endocrine disruptors and non-communicable diseases in Africa

Chiara Frazzoli and Alberto Mantovani from Istituto Superiore di Sanità share their insights into endocrine disruptors and non-communicable diseases in Africa, in collaboration with NOODLES Alliance Network.
antimicrobial adhesive, healthcare-associated infection

FLEXPOL: An antimicrobial adhesive film

The EU-funded project FLEXPOL (GA number 721062) offers an affordable approach to prohibit the spread of bacteria and healthcare-associated infections using cost-effective and sustainable film products.
research into osteoarthritis, clinical research

Impact and early intervention: Clinical research into osteoarthritis

Versus Arthritis speaks to award-winning rheumatologist Dr Fiona Watt about clinical research into osteoarthritis.
clinical contact research

Clinical Contract Research: Building the digital bridge between clinical research and clinical care

Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.
fda approval, new drug

How can you improve your chances of FDA approval?

Here Dr. Harneet Arora, freelance neurologist, and FDA regulations expert, shares her advice on how to submit an application with FDA approval.
Type 1 diabetes treatment

Charities renew investment in Type 1 diabetes treatment

Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
heart failure treatment, erectile dysfunction

Sex drug could be the next heart failure treatment

The University of Manchester found that a drug used for erectile dysfunction can slow or even reverse the progression of heart failure of sheep.
medical cannabis products

Five-year license issued to “Pharma Essenza Cannabis SA” and “PENTE SA”

A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
treatment for psychosis, cbd oil

CBD could be “new class of treatment” for psychosis

King's College London researchers found that cannabidiol (CBD) could hold promise as a treatment for psychosis, according to reasonable benefits seen in a clinical trial.
Tackling tuberculosis

Tackling tuberculosis (TB) in Africa

While Africa has made progress in tackling tuberculosis (TB), it still has one of the highest TB rates in the world and remains a priority.
Oxford Cannabinoid Technologies LTD

Oxford Cannabinoid Technologies – Researching new therapies

Oxford Cannabinoid Technologies is a biopharmaceutical company combining cannabinoid medicine with world class scientific research and drug development.
Alzheimer's brain, Alzheimer's disease research

Scientists reveal largest ever map of human Alzheimer’s brain

On the 4th February 2019, a scientific breakthrough for the future of Alzheimer's brain reserach has been published - read on to explore the developments.
UCL Translational office

UCL Translational Research Office (TRO)

UCL’s Translational Research Office (TRO) builds on an increasingly vibrant translational culture across the university community.
opioids for pain, poor areas

GPs prescribe more opioids for pain in poor Northern areas, study reveals

English patients living in poorer areas are likely to be prescribed more opioids for pain by their GPs, according to a study led by University of Manchester and University of Nottingham researchers.
Neuromuscular disease

Advances in newborn screening for neuromuscular disease

Kristin Stephenson, Sr. VP, Chief Policy & Community Engagement Officer at the Muscular Dystrophy Association details the advances taking place in newborn screening for neuromuscular disease
Organoids

Developmental biology: Fulfilling the promise of Organoids

Professor of Developmental Mechanics at the Department of Genetics, University of Cambridge, Alfonso Martinez Arias shares his expert view on Organoids, within the field of developmental biology.

Follow Open Access Government